Switzer TV

In this week’s Switzer Investing TV, Paul Rickard sits down with chartist and market analyst Mike Gable to break down the big ideas driving today’s bull market — from rare earths and uranium to the comeback stories in healthcare and banking.

They look at what’s powering the ASX200’s latest rally, whether the US market still has room to run, and which sectors could surprise next. Plus, Gable shares how he’s positioning in gold, why CSL might finally be turning the corner, and where he sees upside in Macquarie.

In this episode:

• The ASX200’s breakout — sustainable or overdone?

• Rare earths vs lithium: is history repeating?

• Uranium and gold: the commodities back in focus

• Has CSL bottomed, and what’s next for healthcare?

• The banks and Macquarie — are they about to run again?

If you’re looking for market insight that blends technical charts with fundamental reasoning, this is a must-watch for every Australian investor.

Hosted by Paul Rickard | Guest: Mike Gable, Managing Director, Fairmont Equities.

Switzer Investing TV | 20 Oct 2025: Are rare earths about to get the Lithium hosing? Plus: Can US shares run even higher, and will the ASX200 follow?

We break down the big ideas driving today’s bull market: from rare earths and uranium to the comeback stories in healthcare and banking.

More videos

COVID-19 and your immunity

Dr Ross Walker looks at how your immunity affects your risk of contracting Coronavirus.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for another live episode of Mad about Money.

Series: ,
CEOs of BHP, Coles, Tyro, Domino's, Coca Cola & A2 Milk. Buy or Sell?

Peter Switzer talks to CEOs and a CFO from some of the biggest companies reporting in the past week, plus a catch up with Julia Lee.

Series: ,
COVID-19 vaccine update

Dr Ross Walker explains two promising COVID-19 vaccine trials and what they have been able to achieve.

Series: ,
Mad about Money

Tune in to find out the latest money news locally and overseas with Peter Switzer and Paul Rickard.

Series: ,
The hot companies to follow out of reporting season!

Peter Switzer speaks to Burman Invest's Julia Lee and Shaw and Partners' Adam Dawes about what companies to watch, plus Ruslan Kogan joins the show.

Series: ,
A treatment for mild to moderate COVID-19

Dr Ross Walker shares the details of a treatment plan with positive results in some mild to moderate cases of Coronavirus.

Series: ,
Mad about Money Live

Find out the major money news of the day and how it affects you with Peter Switzer and Paul Rickard.

Series: ,
COVID-19: Great for retail stocks! Plus, these charts will make you want to buy stocks!

On this week's show: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, ELMO's Danny Lessem, Morgans' Raymond Chan and Switzer's Paul Rickard.

Series: ,
How does herd immunity work?

Dr Ross explains herd immunity and how it could work in the case of COVID-19.

Series: ,
Mad about Money Live!

Catch up with Peter Switzer and Paul Rickard for the latest money news locally and overseas.

Series: ,
Afterpay a sell? Top stocks big gains ahead?

Fortescue CEO Elizabeth Gaines joins this week's show, along with Burman Invest's Julia Lee, Shawn and Partners' Adam Dawes and Switzer's Paul Rickard.

Series: ,
1 41 42 43 44 45 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram